Although the scientific principles that link obesity and cancer are broad, most researchers have largely focused on hormone-sensitive cancers, in particular breast and prostate cancer, or on specific adipokines and growth factors, including leptin, adiponectin, insulin, and insulin-like growth factor 1 (IGF-1). Here, LEP is linked to prostate carcinoma.